Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01538810
Other study ID # 201201061
Secondary ID
Status Completed
Phase N/A
First received February 20, 2012
Last updated June 16, 2016
Start date February 2012
Est. completion date May 2016

Study information

Verified date June 2016
Source Washington University School of Medicine
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The purpose of this study is to assemble a collection of urine and blood samples for the development and validation of biomarkers potentially useful in correlating or improving the diagnostic utility of abdominal imaging.


Recruitment information / eligibility

Status Completed
Enrollment 751
Est. completion date May 2016
Est. primary completion date May 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years and older

- Undergoing abdominal CT imaging (standard of care)

- Signed, informed consent

Exclusion Criteria:

- Patients on dialysis

Study Design

Observational Model: Ecologic or Community, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Abdominal CT Imaging Performed as Standard of Care

Locations

Country Name City State
United States Washington University School Of Medicine St. Louis Missouri

Sponsors (1)

Lead Sponsor Collaborator
Washington University School of Medicine

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quantitative measures Confirm the ability of quantitative measure of AQP-1 and ADFP by ELISA from urine and blood samples to develop and validate an assay for patients with renal cancer. at enrollment No
Secondary differentiation of cancerous from non-cancerous renal mass Correct determination of tumor burden and differentiation of cancerous from non-cancerous renal mass. at analysis No